Infant, Very Low Birth Weight

• 

  Subject Areas on Research

  • A 6th Vital Sign--Potential Use of Nasogastric Tube for Intra-abdominal Pressure Monitoring Method to Detect Feeding Intolerance in Very Low Birth-Weight Preterm Infants (<1500 g). 
  • A blinded, randomized, multicenter study of an intravenous Staphylococcus aureus immune globulin. 
  • A predictive model for extubation readiness in extremely preterm infants. 
  • Accuracy of the 7-8-9 Rule for endotracheal tube placement in the neonate. 
  • Acute care of high-risk infants. 
  • Anaerobic antimicrobial therapy after necrotizing enterocolitis in VLBW infants. 
  • Antihypertensive drug exposure in premature infants from 1997 to 2013. 
  • Assessment of risk factors for infantile cataracts using a case-control study: National Birth Defects Prevention Study, 2000-2004. 
  • Association between Furosemide Exposure and Patent Ductus Arteriosus in Hospitalized Infants of Very Low Birth Weight. 
  • Association between early echocardiography, therapy for patent ductus arteriosus, and outcomes in very low birth weight infants. 
  • Association between early postnatal weight loss and death or BPD in small and appropriate for gestational age extremely low-birth-weight infants. 
  • Association of Adverse Hearing, Growth, and Discharge Age Outcomes With Postnatal Cytomegalovirus Infection in Infants With Very Low Birth Weight. 
  • Association of Atrial Septal Defects and Bronchopulmonary Dysplasia in Premature Infants. 
  • Association of H2-blocker therapy and higher incidence of necrotizing enterocolitis in very low birth weight infants. 
  • Association of Postnatal Cytomegalovirus Infection With Head Growth-Reply. 
  • Associations Between Hormonal Biomarkers and Cognitive, Motor, and Language Developmental Status in Very Low Birth Weight Infants. 
  • Associations Between Hormonal Biomarkers and Preterm Infant Health and Development During the First 2 Years After Birth. 
  • Associations of Hormonal Biomarkers With Mental Health and Healthy Behaviors Among Mothers of Very-Low-Birthweight Infants. 
  • Associations of Maternal Testosterone and Cortisol Levels With Health Outcomes of Mothers and Their Very-Low-Birthweight Infants. 
  • Associations of Maternal and Infant Testosterone and Cortisol Levels With Maternal Depressive Symptoms and Infant Socioemotional Problems. 
  • Attention problems in very low birth weight preschoolers: are new screening measures needed for this special population? 
  • Bacterial meningitis in infants. 
  • Behavioral characteristics of very-low-birth-weight infants of varying biologic risk at 6, 15, and 24 months of age. 
  • Blood stream infection is associated with altered heptavalent pneumococcal conjugate vaccine immune responses in very low birth weight infants. 
  • Body temperature instability and respiratory morbidity in the very low birth weight infant: a multiple case, intensive longitudinal study. 
  • Bronchopulmonary Dysplasia and Perinatal Characteristics Predict 1-Year Respiratory Outcomes in Newborns Born at Extremely Low Gestational Age: A Prospective Cohort Study. 
  • Bronchopulmonary dysplasia impairs L-type amino acid transporter-1 expression in human and baboon lung. 
  • Burnout in the neonatal intensive care unit and its relation to healthcare-associated infections. 
  • Case report: total parenteral nutrition extravasation associated with spinal cord compression and necrosis. 
  • Causes and timing of death in extremely premature infants from 2000 through 2011. 
  • Changes in mortality and morbidities among infants born at less than 25 weeks during the post-surfactant era. 
  • Clinical characteristics and response to prophylactic fluconazole of preterm VLBW neonates with baseline and acquired fungal colonisation in NICU: data from a multicentre RCT. 
  • Clinical outcomes in very low birth weight infants with major congenital heart defects. 
  • Cost-effectiveness of prophylactic indomethacin in very-low-birth-weight infants. 
  • Development and validation of the Proxy-Reported Pulmonary Outcomes Scale for premature infants. 
  • Developmental outcome of very low birth weight infants at four years of age as a function of biological risk and psychosocial risk. 
  • Does preterm period sleep development predict early childhood growth trajectories? 
  • Dynamic change of fecal calprotectin in very low birth weight infants during the first month of life. 
  • Early Caffeine Prophylaxis and Risk of Failure of Initial Continuous Positive Airway Pressure in Very Low Birth Weight Infants. 
  • Early and late onset sepsis in very-low-birth-weight infants from a large group of neonatal intensive care units. 
  • Early lumbar puncture and risk of intraventricular hemorrhage in very low birth weight infants. 
  • Early sepsis does not increase the risk of late sepsis in very low birth weight neonates. 
  • Effect of fluconazole prophylaxis on candidiasis and mortality in premature infants: a randomized clinical trial. 
  • Effects of low-dose dopamine on urine output in normotensive very low birth weight neonates. 
  • Elucidating the role of genomics in neonatal sepsis. 
  • Empirical therapy for neonatal candidemia in very low birth weight infants. 
  • Enteral glutamine supplementation for very low birth weight infants decreases morbidity. 
  • Evaluation of criteria for chronic lung disease in surviving very low birth weight infants. Newborn Lung Project. 
  • Factors in Premature Infants Associated With Low Risk of Developing Retinopathy of Prematurity. 
  • Fear of litigation may increase resuscitation of infants born near the limits of viability. 
  • Feeding practices and other risk factors for developing transfusion-associated necrotizing enterocolitis. 
  • First, do no harm. 
  • Fluconazole prophylaxis for prevention of invasive candidiasis in infants. 
  • Functional assessment of a multicenter very low-birth-weight cohort at age 5 years. Newborn Lung Project. 
  • Furosemide Exposure and Prevention of Bronchopulmonary Dysplasia in Premature Infants. 
  • Heptavalent pneumococcal conjugate vaccine immunogenicity in very-low-birth-weight, premature infants. 
  • High mortality rates for very low birth weight infants in developing countries despite training. 
  • Immunogenicity of Haemophilus influenzae type b protein conjugate vaccines in very low birth weight infants. 
  • Improved Use of Human Milk, Growth, and Central Line Utilization With Standard Feeding Roadmap in an Academic NICU. 
  • Infant arousal in an en-face exchange with a new partner: effects of prematurity and perinatal biological risk. 
  • Integrating neurocritical care approaches into neonatology: should all infants be treated equitably? 
  • Is an increased dwell time of a peripherally inserted catheter associated with an increased risk of bloodstream infection in infants? 
  • Late-onset sepsis in very low birth weight infants from singleton and multiple-gestation births. 
  • Maternal cytomegalovirus-specific immune responses and symptomatic postnatal cytomegalovirus transmission in very low-birth-weight preterm infants. 
  • Modeling adverse birth outcomes via confirmatory factor quantile regression. 
  • Mortality and morbidity of VLBW infants with trisomy 13 or trisomy 18. 
  • Multicenter Trial of Cryotherapy for Retinopathy of Prematurity: ophthalmological outcomes at 10 years. 
  • Necrotizing enterocolitis and the use of loop diuretics in very low birth weight neonates. 
  • Neonatal candidiasis among extremely low birth weight infants: risk factors, mortality rates, and neurodevelopmental outcomes at 18 to 22 months. 
  • Neurodevelopmental outcomes in infants requiring resuscitation in developing countries. 
  • Optimizing protein intake in premature infants: a neonatal quality improvement project. 
  • Parent-child interaction and attention regulation in children born prematurely. 
  • Parental Perceptions of Weight Status in Preterm Compared with Term Infants. 
  • Patterns of distress in African-American mothers of preterm infants. 
  • Poorer neurodevelopmental outcomes associated with cystoid macular edema identified in preterm infants in the intensive care nursery. 
  • Postnatal Cytomegalovirus Infection and the Risk for Bronchopulmonary Dysplasia. 
  • Prediction of bronchopulmonary dysplasia by postnatal age in extremely premature infants. 
  • Predictors of Prolonged Breast Milk Provision to Very Low Birth Weight Infants. 
  • Prevention and management of bronchopulmonary dysplasia: Lessons learned from the neonatal research network. 
  • Racial/Ethnic Disparity in NICU Quality of Care Delivery. 
  • Racial/ethnic differences in necrotizing enterocolitis incidence and outcomes in premature very low birth weight infants. 
  • Real-time, computer-assisted quantification of plus disease in retinopathy of prematurity at the bedside. 
  • Regional variation in antenatal corticosteroid use: a network-level quality improvement study. 
  • Reliability of CXR for the diagnosis of bronchopulmonary dysplasia. 
  • Respiratory Support for Very Low Birth Weight Infants Receiving Dexamethasone. 
  • Respiratory symptoms at age 8 years in a cohort of very low birth weight children. 
  • Retinal imaging in premature infants using the Pictor noncontact digital camera. 
  • Retinopathy of prematurity in the United States. 
  • Retinopathy of prematurity risk prediction for infants with birth weight less than 1251 grams. 
  • Rifampin use and safety in hospitalized infants. 
  • Risk factors for postpartum depressive symptoms in low-income women with very low-birth-weight infants. 
  • Risk of development of treated retinopathy of prematurity in very low birth weight infants. 
  • Risk of necrotizing enterocolitis in very-low-birth-weight infants with isolated atrial and ventricular septal defects. 
  • Safety climate, safety climate strength, and length of stay in the NICU. 
  • Safety of histamine-2 receptor blockers in hospitalized VLBW infants. 
  • Sildenafil and retinopathy of prematurity risk in very low birth weight infants. 
  • Single grading vs double grading with adjudication in the telemedicine approaches to evaluating acute-phase retinopathy of prematurity (e-ROP) study. 
  • Symptomatic Postnatal Cytomegalovirus Testing among Very Low-Birth-Weight Infants: Indications and Outcomes. 
  • Systematic Review and Meta-analysis: Gene Association Studies in Neonatal Sepsis. 
  • Teamwork in the NICU Setting and Its Association with Health Care-Associated Infections in Very Low-Birth-Weight Infants. 
  • The Association of Level of Care With NICU Quality. 
  • The Early Treatment for Retinopathy Of Prematurity Study: structural findings at age 2 years. 
  • The association of third-generation cephalosporin use and invasive candidiasis in extremely low birth-weight infants. 
  • The effects of bedside blood gas monitoring on blood loss and ventilator management. 
  • The relation of maternal complications to outcomes in very low birthweight infants in an era of changing neonatal care. 
  • The relationship of poor linear growth velocity with neonatal illness and two-year neurodevelopment in preterm infants. 
  • Thermoregulation and heat loss prevention after birth and during neonatal intensive-care unit stabilization of extremely low-birthweight infants. 
  • Thyroxine supplementation in preterm infants: critical analysis. 
  • Timing of Multiorgan Dysfunction among Hospitalized Infants with Fatal Fulminant Sepsis. 
  • Transpyloric tube feeding in very low birthweight infants with suspected gastroesophageal reflux: impact on apnea and bradycardia. 
  • Validated System for Centralized Grading of Retinopathy of Prematurity: Telemedicine Approaches to Evaluating Acute-Phase Retinopathy of Prematurity (e-ROP) Study. 
  • Validity of a telemedicine system for the evaluation of acute-phase retinopathy of prematurity. 
  • Very late onset infections in the neonatal intensive care unit. 
  • Very low birth weight neonates who survive early-onset sepsis do not have an increased risk of developing late-onset sepsis. 
  • Very low birth weight preterm infants with early onset neonatal sepsis: the predominance of gram-negative infections continues in the National Institute of Child Health and Human Development Neonatal Research Network, 2002-2003. 
  • When to suspect fungal infection in neonates: A clinical comparison of Candida albicans and Candida parapsilosis fungemia with coagulase-negative staphylococcal bacteremia. 
  • Wide variation in caffeine discontinuation timing in premature infants. 
• 

  Keywords of People

  • Cohen-Wolkowiez, Michael, Professor of Pediatrics, Pediatrics, Infectious Diseases